VYNE Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
/ 
Frequently asked questions
To buy VYNE Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for VYNE Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for VYNE Therapeutics Inc. is VYNE:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
VYNE Therapeutics Inc. has its primary listing on NASDAQ. You can trade VYNE Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, VYNE Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include VYNE Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like VYNE Therapeutics Inc..